Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Viva Biotech Awarded 'Top 10 Public Companies' 2019-12-24 18:18
Bridge Biotherapeutics Files Investigational New Drug Application for BBT-176, an EGFR TKI for NSCLC 2019-12-20 10:19
Specialised Therapeutics Signs Exclusive Deal for New Haematology Drug 2019-12-18 22:00
Dr. Jie Jack Li joins Shanghai ChemPartner as a Vice President of Discovery Chemistry 2019-12-18 00:00
iX Biopharma Reports on Outcome of Wafermine End-of-phase 2 Meeting with US FDA 2019-12-11 22:00
Gracell Announces Progressive Outcomes from Multiple Human Clinical Trials to Investigate FasTCAR and Dual CAR Cell Platform Technologies 2019-12-09 22:00
Hebron Announces $6.5 Million Private Placement 2019-12-09 21:30
BJ Bioscience Announces First Patient Dosed in FIH Trial of BJ-001 in Patients with Locally Advanced/Metastatic Solid Tumors 2019-12-09 21:00
Lumosa Announces FDA Acceptance of IND Application for LT1001, an Extended-Release Analgesic Injection - Lumosa to Initiate the Bridging Study in the US 2019-12-03 17:36
New Early Breast Cancer Drug Approved by Singapore Health Sciences Authority 2019-12-03 05:30
Innovent Presents Co-developed Cancer-Fighting Tyvyt(R) (Sintilimab Injection) at CIIE 2019 with Eli Lilly 2019-12-02 09:37
Ascentage Pharma Breaks Ground on its Global Headquarters, R&D Center and Manufacturing Facility in the Suzhou Industrial Park 2019-11-21 11:30
3SBio Selects Verseau's PSGL-1-targeted Antibody VTX-0811 as First Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration 2019-11-18 08:30
Viva Biotech Partnership Summit Successfully Launched in Shanghai 2019-11-15 14:16
I-Mab Biopharma Receives IND Approval from NMPA to Initiate Clinical Trials for its Anti-GM-CSF Monoclonal Antibody TJM2 in China 2019-11-14 23:45
Samsung Biologics Enhances Its Trusted Service as the First and Only ISO27001 Certified CDMO 2019-11-14 20:00
China Biologic Reports Financial Results for the Third Quarter of 2019 2019-11-14 05:43
Akesobio Presents Phase 1 Clinical Data from First-in-class Bispecific Drug Candidate AK104 (PD1/CTLA4) As Oral Presentation, at 2019 SITC Annual Meeting 2019-11-11 17:35
Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost 2019-11-07 20:24
TransThera Biosciences Lead Product TT-00420 Granted Orphan Drug Designation from FDA to Treat Cholangiocarcinoma 2019-11-07 20:08
1 124 125 126 127 128 165